Published in Health Business Week, February 27th, 2009
Bonal's nine month year-to-date revenue is down 24%. Third quarter sales are down 31% over last year to $408,917 and Bonal had a slight loss of $(14,232), which is down from a profit of $97,468 last year. Bonal's per share quarterly loss is $ (0.01) compared to $0.06 last year. Earnings for the nine months are $49,868 down from $388,192 last year. Earnings per share for the nine month period went from $0.23 last year to $0.03 per share on Dec. 31, 2008.
"Equipment sales continue to be down due to the nervousness in the industry because of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.